Abstract
Low dose methotrexate has been used successfully to treat patients with refractory rheumatoid arthritis. Methotrexate-induced pneumonitis occurs in about 1 to 5% of patients, although opportunistic infections have also been reported. We report a case of fatal pneumocystis carinii pneumonia (PCP) in an otherwise healthy female patient treated with methotrexate for rheumatoid arthritis and review the literature.
| Original language | English |
|---|---|
| Pages (from-to) | 25-26 |
| Number of pages | 2 |
| Journal | CPD Journal Acute Medicine |
| Volume | 2 |
| Issue number | 1 |
| Publication status | Published - 2003 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Free Keywords
- Methotrexate
- Pneumocystis carinii pneumonia
ASJC Scopus subject areas
- Internal Medicine
- Critical Care and Intensive Care Medicine
Fingerprint
Dive into the research topics of 'Fatal pneumocystis carinii pneumonia as a complication of methotrexate in rheumatoid arthritis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver